2025-04-23 | Company
Facility Update from Sever Pharma Solutions – Putnam, CT, USA
In 2024, our Putnam site fully commissioned and qualified two new High Potent API processing suites.
2025-04-23 | Company
In 2024, our Putnam site fully commissioned and qualified two new High Potent API processing suites.
2025-04-07 | Company
Sever Pharma Solutions is pleased to announce Ulrike Foley as the new Head of Global Business Development and Marketing.
2025-03-26 | Company
Sever Pharma Solutions is proud to be prominently featured in the 2024 Citeline Annual Report on Medicon Valley.
2024-11-19 | Company
The year 2023 has proven successful, especially in the United States. Revenues increased by 50 percent, with significant improvements in profit margins.
2024-11-14 | Company
Sever Pharma Solutions is proud to be prominently featured in the 2024 Citeline Annual Report on Medicon Valley.
2024-08-30 | Company
We are happy to announce that Stefan Petersson has been appointed as Global HR Director.
2023-12-21 | Company
Sever Pharma Solutions, a leading Contract Development and Manufacturing Organization (CDMO) specializing in controlled release systems for highly potent drugs is pleased to announce the successful attainment of the Drug Enforcement Administration (DEA) license for its site in Putnam, CT.
2023-10-18 | Company
We pleased to announce the approval by the Swedish Health authorities of its state-of-the-art aseptic filling line for syringes, specifically designed for high potent injectable drugs, at its Malmo site.
2023-10-11 | Company
We are happy to announce that Kristian Ahlgren has been appointed as Director of Supply Chain Management.
2023-09-21 | Company
[Putnam, CT, USA - Sever Pharma Solutions, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced the groundbreaking of its new high potency active pharmaceutical ingredients (HPAPI) manufacturing suites.